IVERIC bio (ISEE) Environmental, Social & Governance (ESG) Data

Company Profile

Search within these filings

View filings

Exhibits within filings

Filing insights

Export filings list

Export a CSV file of filings or unique filing companies (up to first 5,000 results).

Download list of filings Download list of companies

Employees

Data from SEC filings

Employee count

CEO pay ratio

CEO Salary

Median Employee Salary

ESG framework mentions

In last year of SEC filings

Sustainability Accounting Standards Board (SASB)

No mentions

Global Reporting Initiative (GRI)

No mentions

Task Force on Climate-related Financial Disclosures (TCFD)

No mentions

UN Sustainable Development Goals (SDGs)

No mentions

ESG term mentions

In last year of SEC filings

Agriculture Biodegradable Circular Climate Climate Change Emission Environment Environmental Lifecycle Materials Nature Offset Package Packaging Pandemic Raw Materials Regenerative Scarcity Toxic Waste Access Affordability African American Benefits Black California Consumer Privacy Act Community Culture Customer Cyber Cybersecurity Data Privacy Data Security Death Demographic Demographics Disability Diversity Diversity and Inclusion Drug Pricing Employee Engagement Ethnic Gender General Data Protection Regulation Health and Safety Health Care Healthcare Hire Hiring Human Capital Human Resources Incident Injuries Injury Minority Perquisites Privacy Product Quality Recall Recruit Recruitment Reimbursement Retention Retirement Safety Satisfaction Skill Skills Social Society Stakeholder Supplier Supply Chain Supply Chain Management Talent Training Union Women Workers Workforce Anti-corruption Assessment Assurance Attorneys General Audit Board Oversight Bonus Bribery Chronic Class Action Lawsuit Classified Classified Board Clawback Commitment Corporate Governance Corporate Purpose Department of ESG Ethics Executive Compensation Expert Fraud Goals Governance Hedging Incentive Incentivize Independence Independent Independent Lead Director Innovation Innovative Investigation Lawsuit Leadership Litigation Long-term Majority Mission Other Public Company Boards Overboarding Oversee Oversight Perquisite Plaintiff Pledging Poison Pill Procurement Purpose Quality Standard R&D Recoup Reputation Reputational Research and Development Responsibility Responsible Self-evaluation Stockholder Outreach Strategy Sustainability Targets Tax Tenure Transparency Transparent Voting Rights

Shareholder alignment

Proxy contests and exempt solicitations in last 3 years

No recent proxy contest or exempt solicitation filings from shareholders.

Vote support at last AGM

IVERIC bio, Inc. ("IVERIC") held its 2022 annual meeting of stockholders on May 12, 2022. The following is a summary of the matters voted on at that meeting.

(a) IVERIC’s stockholders elected Dr. Adrienne Graves and Ms. Christine Miller as Class III directors to serve until the 2025 annual meeting of stockholders, each such director to hold office until her successor has been duly elected and qualified. The results of the stockholders’ vote for the election of such Class III directors were as follows:

	For	Withheld	Broker Non-Votes

Adrienne Graves	84,393,059	8,395,468	11,268,075
Christine Miller	92,685,329	103,198	11,268,075

(b) IVERIC’s stockholders approved a non-binding, advisory proposal on the compensation of IVERIC’s named executive officers, as described in the definitive proxy statement for the 2022 annual meeting of stockholders. The results of the stockholders’ vote for such matter were as follows:

For						Against						Abstain						Broker Non-Votes

91,162,825						1,602,973						22,729						11,268,075

(c) IVERIC’s stockholders recommended, in a non-binding, advisory vote, that future advisory votes on the compensation of the Company’s named executive officers be held with a frequency of every one year. The results of the stockholders’ vote with respect to such matter were as follows:


1 Year	2 Years	3 Years	Abstain	Broker Non-Votes
91,544,190	31,751	1,175,710	36,876	11,268,075

Consistent with these results, IVERIC's Board of Directors determined that future advisory votes on named executive officer compensation will be held every year until the next required advisory vote on the frequency of shareholder votes on executive compensation.

(d) IVERIC’s stockholders ratified the selection of Ernst & Young LLP as IVERIC’s independent registered public accounting firm for the current fiscal year. The results of the stockholders’ vote for such matter were as follows:

For						Against						Abstain						Broker Non-Votes

103,982,814						55,418						18,370						0